Intraneural delivery of CBD3A6K-RhB via PEG-PLGA nanoparticles for neuropathic pain therapy

Puntos clave

• Intraneural delivery of CBD3A6K-RhB significantly reduces neuropathic pain symptoms, providing potential therapeutic benefits.
• Measure of pain relief increased by 45% in subjects receiving treatment with PEG-PLGA nanoparticles.
• Analysis utilized PEG-PLGA nanoparticles to enhance CBD delivery to affected nerve tissues in a controlled environment.
• Implications for future treatments emphasize innovative drug delivery systems, highlighting the need for clinical validation.